MM3 Stock Overview
Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MM3 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Merit Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$93.50 |
| 52 Week High | US$102.00 |
| 52 Week Low | US$65.00 |
| Beta | 0.84 |
| 1 Month Change | -6.50% |
| 3 Month Change | 6.25% |
| 1 Year Change | 36.50% |
| 3 Year Change | 70.00% |
| 5 Year Change | 231.56% |
| Change since IPO | 811.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| MM3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.6% | -2.9% | -2.6% |
| 1Y | 36.5% | -8.5% | 6.9% |
Return vs Industry: MM3 exceeded the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: MM3 exceeded the German Market which returned 6.9% over the past year.
Price Volatility
| MM3 volatility | |
|---|---|
| MM3 Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MM3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: MM3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 6,950 | Fred Lampropoulos | www.merit.com |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
Merit Medical Systems, Inc. Fundamentals Summary
| MM3 fundamental statistics | |
|---|---|
| Market cap | €5.49b |
| Earnings (TTM) | €115.05m |
| Revenue (TTM) | €1.27b |
47.7x
P/E Ratio4.3x
P/S RatioIs MM3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MM3 income statement (TTM) | |
|---|---|
| Revenue | US$1.33b |
| Cost of Revenue | US$704.99m |
| Gross Profit | US$620.88m |
| Other Expenses | US$500.84m |
| Earnings | US$120.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.06 |
| Gross Margin | 46.83% |
| Net Profit Margin | 9.05% |
| Debt/Equity Ratio | 56.7% |
How did MM3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 23:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Merit Medical Systems, Inc. is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| Ishan Majumdar | Baptista Research |
| Michael Petusky | Barrington Research Associates, Inc. |